Inventor
FAOUR JOAQUINA
AR38 patents
⚠️ This page may combine multiple inventors who share the name “FAOUR JOAQUINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OSMOTICA CORP
18 patentsUS6599284B2Jul 29, 2003
Osmotic device having a preformed passageway that increases in size
OSMOTICA CORP175 citations99
US6352721B1Mar 5, 2002
Combined diffusion/osmotic pumping drug delivery system
OSMOTICA CORP213 citations99
US6753011B2Jun 22, 2004
Combined diffusion/osmotic pumping drug delivery system
OSMOTICA CORP127 citations98
US6491949B2Dec 10, 2002
Osmotic device within an osmotic device
OSMOTICA CORP204 citations97
US6605302B2Aug 12, 2003
Drug delivery device containing oseltamivir and an H1 antagonist
OSMOTICA CORP47 citations96
US6569456B2May 27, 2003
Osmotic device containing diltiazem and an ACE inhibitor or diuretic
OSMOTICA CORP72 citations96
US6572890B2Jun 3, 2003
Osmotic device containing venlafaxine and an anti-psychotic agent
OSMOTICA CORP62 citations93
US7208176B2Apr 24, 2007
Drug delivery device containing neuraminidase inhibitor and an H1 antagonist
OSMOTICA CORP16 citations92
US6676933B2Jan 13, 2004
Pharmaceutical composition containing mosapride and pancreatin
OSMOTICA CORP21 citations92
US6613357B2Sep 2, 2003
Osmotic device containing pseudoephedrine and an H1 antagonist
OSMOTICA CORP48 citations92
US6599532B2Jul 29, 2003
Osmotic device containing alprazolam and an antipsychotic agent
OSMOTICA CORP39 citations92
US6521255B2Feb 18, 2003
Osmotic device containing ranitidine and a prokinetic agent
OSMOTICA CORP28 citations92
US7569794B2Aug 4, 2009
Laser drilling system and method
OSMOTICA CORP19 citations86
USRE39069EApr 18, 2006
Multi-layered osmotic device
OSMOTICA CORP28 citations86
US7008641B2Mar 7, 2006
Osmotic device containing venlafaxine and an anti-psychotic agent
OSMOTICA CORP13 citations81
US6809288B2Oct 26, 2004
Laser drilling system and method
OSMOTICA CORP10 citations74
US7147870B2Dec 12, 2006
Osmotic device containing pseudoephedrine and an H1 antagonist
OSMOTICA CORP4 citations62
US6458808B1Oct 1, 2002
Pharmaceutical composition for the treatment of cognitive cerebrovascular disease
OSMOTICA CORP1 citations45
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG
5 patentsUS10213394B1Feb 26, 2019
Composition and method for treating neurological disease
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG7 citations82
US10512617B2Dec 24, 2019
Composition and method for treating neurological disease
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG2 citations71
US10500172B2Dec 10, 2019
Composition and method for treating neurological disease
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG2 citations71
US10500170B2Dec 10, 2019
Composition and method for treating neurological disease
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG1 citations71
US10500171B2Dec 10, 2019
Composition and method for treating neurological disease
OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG2 citations71
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
5 patentsUS10265308B2Apr 23, 2019
Dose-dumping resistant controlled release dosage form
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT2 citations71
US9855258B1Jan 2, 2018
Dose-dumping resistant controlled release dosage form
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT3 citations71
US9827234B1Nov 28, 2017
Dose-dumping resistant controlled release dosage form
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT2 citations71
US9707217B1Jul 18, 2017
Dose-dumping resistant controlled release dosage form
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT2 citations71
US10695336B2Jun 30, 2020
Dose-dumping resistant controlled release dosage form
OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT0 citations50